75770-8
Thioridazine [Presence] in Blood or Urine by Screen method
Active
Part Description
LP16290-6 Thioridazine
Thioridazine (Mellaril, Melleril, Sonapax, Thioril) is a piperidine typical antipsychotic drug of the phenothiazine drug class and was previously widely used in the treatment of schizophrenia and psychosis. Due to concerns about cardiotoxicity and retinopathy at high doses it has been withdrawn in many countries (including the UK and Australia) and in other countries it is not commonly prescribed, reserved for patients who have failed to respond to, or have contraindications for, more widely used antipsychotics. It has been tried with some success as a treatment for various psychiatric symptoms seen in patients with dementia. Thioridazine is known to kill intracellular extensively drug-resistant (XDR) Mycobacterium tuberculosis and both inhibit MRSA directly but also increase the susceptibility of MRSA to β-lactam antibiotics at clinical concentrations. It also appears to increase the efficacy of standard antimicrobial agents (even ones to which the strain in question is resistant) in treating XDR-tuberculosis (XDR-TB) via inhibiting bacterial efflux pumps.(Wikipedia)
Source: Regenstrief LOINC, Thioridazine
Fully-Specified Name
- Component
- Thioridazine
- Property
- PrThr
- Time
- Pt
- System
- Bld/Urine
- Scale
- Ord
- Method
- Screen
Additional Names
- Short Name
- Thioridazine Bld/Urn Ql Scn
- Display Name
- Thioridazine Screen Ql (Bld/U)
- Consumer Name Alpha Get Info
- Thioridazine, Blood or urine
Example Answer List: LL2875-4
Source: Laboratory Corporation of America| Answer | Code | Score | Answer ID |
|---|---|---|---|
| NegativeCopyright http://snomed.info/sct ID:260385009 Negative (qualifier value) | LA6577-6 | ||
| Small amount | LA20973-6 | ||
| Moderate amount | LA20974-4 | ||
| Large amount | LA20975-1 |
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.73
- Change Reason
- The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 18538
Member of these Panels
| LOINC | Long Common Name |
|---|---|
| 75815-1 | Antipsychotics drug panel - Blood or Urine by Screen method |
| 98966-5 | Antipsychotics drug panel - Urine by Confirmatory method |
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-ES | Spanish (Spain) | Tioridazina: |
| es-MX | Spanish (Mexico) | Tioridazina: |
| fr-FR | French (France) | Thioridazine: |
| it-IT | Italian (Italy) | Tioridazina: Synonyms: Livelli farmacologici e tossicologia Presenza o Soglia Punto nel tempo (episodio) Sangue Sangue o Urine Screening tossicologico |
| nl-NL | Dutch (Netherlands) | thioridazine: |
| tr-TR | Turkish (Turkey) | Tiyoridazin: Synonyms: Mevcut |
| zh-CN | Chinese (China) | 甲硫哒嗪: Synonyms: 10-β-甲基哌啶乙基-2-甲硫基吩噻嗪; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=75770-8
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright